Please enable Javascript

Labmeeting uses lots of Javascript - basically you can't use the site without it. So please enable Javascript in your browser. If your browser does not support Javascript, we recommend Firefox.

Papers authored by Yellon DM

Collect these papers and discover other ones on Labmeeting. Learn more.

The cannabinoid CB1 receptor antagonist, rimonabant, protects against acute myocardial infarction.

+ cite this

+ View Abstract

Lim SY, Davidson SM, Yellon DM, and Smith CC

Basic research in cardiology 104(6):781-92, 2009 Nov - Who cited this? | PubMed ID: 19462153 | Fulltext

Remote ischaemic preconditioning reduces myocardial injury in patients undergoing cardiac surgery with cold-blood cardioplegia: a randomised controlled trial.

+ cite this

+ View Abstract

Venugopal V, Hausenloy DJ, Ludman A, Di Salvo C, Kolvekar S, Yap J, Lawrence D, Bognolo J, and Yellon DM

Heart (British Cardiac Society) 95(19):1567-71, 2009 Oct - Who cited this? | PubMed ID: 19508973 | Fulltext

Enhancing cardiovascular disease risk reduction: raising high-density lipoprotein levels.

+ cite this

+ View Abstract

Hausenloy DJ and Yellon DM

Current opinion in cardiology 24(5):473-82, 2009 Sep - Who cited this? | PubMed ID: 19574922 | Fulltext

Cardioprotective growth factors.

+ cite this

+ View Abstract

Hausenloy DJ and Yellon DM

Cardiovascular research 83(2):179-94, 2009 Jul 15 - Who cited this? | PubMed ID: 19218286 | Fulltext

Preconditioning and postconditioning: underlying mechanisms and clinical application.

+ cite this

+ View Abstract

Hausenloy DJ and Yellon DM

Atherosclerosis 204(2):334-41, 2009 Jun - Who cited this? | PubMed ID: 19081095 | Fulltext

'Conditioning' the heart during surgery.

+ cite this

+ View Abstract

Venugopal V, Ludman A, Yellon DM, and Hausenloy DJ

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 35(6):977-87, 2009 Jun - Who cited this? | PubMed ID: 19324569 | Fulltext

The divergent roles of protein kinase C epsilon and delta in simulated ischaemia-reperfusion injury in human myocardium.

+ cite this

+ View Abstract

Sivaraman V, Hausenloy DJ, Kolvekar S, Hayward M, Yap J, Lawrence D, Di Salvo C, and Yellon DM

Journal of molecular and cellular cardiology 46(5):758-64, 2009 May - Who cited this? | PubMed ID: 19248786 | Fulltext

Metformin prevents myocardial reperfusion injury by activating the adenosine receptor.

+ cite this

+ View Abstract

Paiva M, Riksen NP, Davidson SM, Hausenloy DJ, Monteiro P, Gonçalves L, Providência L, Rongen GA, Smits P, Mocanu MM, and Yellon DM

Journal of cardiovascular pharmacology 53(5):373-8, 2009 May - Who cited this? | PubMed ID: 19295441 | Fulltext

Statins and cardioprotection - More than just lipid lowering?.

+ cite this

+ View Abstract

Ludman A, Venugopal V, Yellon DM, and Hausenloy DJ

Pharmacology & therapeutics 122(1):30-43, 2009 Apr - Who cited this? | PubMed ID: 19318042 | Fulltext

The Cardioprotective Actions of Leptin Are Lost in the Zucker Obese (fa/fa) Rat.

+ cite this

+ View Abstract

Dixon RA, Davidson SM, Wynne AM, Yellon DM, and Smith CC

Journal of cardiovascular pharmacology 53(4):311-7, 2009 Apr - Who cited this? | PubMed ID: 19390347 | Fulltext

Premature meta-analysis of remote ischemic preconditioning.

+ cite this

Ludman AJ, Hausenloy DJ, Venugopal V, and Yellon DM

The American journal of cardiology 103(6):893-4, 2009 Mar 15 - Who cited this? | PubMed ID: 19268754 | Fulltext

The mitochondrial permeability transition pore as a target for preconditioning and postconditioning.

+ cite this

+ View Abstract

Hausenloy DJ, Ong SB, and Yellon DM

Basic research in cardiology 104(2):189-202, 2009 Mar - Who cited this? | PubMed ID: 19242644 | Fulltext

Myocardial protection: is primary PCI enough?.

+ cite this

Hausenloy DJ and Yellon DM

Nature clinical practice. Cardiovascular medicine 6(1):12-3, 2009 Jan - Who cited this? | PubMed ID: 18852713 | Fulltext

Letter to the editor: "Zinc and cardioprotection: the missing link".

+ cite this

Mocanu MM and Yellon DM

American journal of physiology. Heart and circulatory physiology 296(1):H233-4, 2009 Jan - Who cited this? | PubMed ID: 19116335 | Fulltext

Urocortin: a protective peptide that targets both the myocardium and vasculature.

+ cite this

+ View Abstract

Davidson SM and Yellon DM

Pharmacological reports : PR 61(1):172-82, 2009 - Who cited this? | PubMed ID: 19307705 | Fulltext

Ischemia-reperfusion injury and cardioprotection: investigating PTEN, the phosphatase that negatively regulates PI3K, using a congenital model of PTEN haploinsufficiency.

+ cite this

+ View Abstract

Siddall HK, Warrell CE, Yellon DM, and Mocanu MM

Basic research in cardiology 103(6):560-8, 2008 Nov - Who cited this? | PubMed ID: 18604624 | Fulltext

Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.

+ cite this

+ View Abstract

Hausenloy DJ and Yellon DM

Postgraduate medical journal 84(997):590-8, 2008 Nov - Who cited this? | PubMed ID: 19103817 | Fulltext

Mitochondrial PINK1-A Novel Cardioprotective Kinase?.

+ cite this

Siddall HK, Warrell CE, Davidson SM, Mocanu MM, and Yellon DM

Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy, 2008 Sep 30 - Who cited this? | PubMed ID: 18825492 | Fulltext

Clinical translation of cardioprotective strategies : Report and recommendations of the Hatter Institute 5th International Workshop on Cardioprotection.

+ cite this

Hausenloy DJ and Yellon DM

Basic research in cardiology 103(5):493-500, 2008 Sep - Who cited this? | PubMed ID: 18600363 | Fulltext

GLP-1 therapy: beyond glucose control.

+ cite this

Hausenloy DJ and Yellon DM

Circulation. Heart failure 1(3):147-9, 2008 Sep - Who cited this? | PubMed ID: 19808284 | Fulltext

Wake Up and Smell the Coffee: Yet Another No Go for Cardiac Patients? : Editorial to "Caffeinated Coffee Blunts the Myocardial Protective Effects of Statins Against Ischemia-reperfusion Injury in the Rat" by Ye et al.

+ cite this

Riksen NP, Hausenloy DJ, and Yellon DM

Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 22(4):257, 2008 Aug - Who cited this? | PubMed ID: 18415673 | Fulltext

Remote ischaemic preconditioning: underlying mechanisms and clinical application.

+ cite this

+ View Abstract

Hausenloy DJ and Yellon DM

Cardiovascular research 79(3):377-86, 2008 Aug 1 - Who cited this? | PubMed ID: 18456674 | Fulltext

Glycogen synthase kinase-3 inactivation is not required for ischemic preconditioning or postconditioning in the mouse.

+ cite this

+ View Abstract

Nishino Y, Webb IG, Davidson SM, Ahmed AI, Clark JE, Jacquet S, Shah AM, Miura T, Yellon DM, Avkiran M, and Marber MS

Circulation research 103(3):307-14, 2008 Aug 1 - Who cited this? | PubMed ID: 18583716 | Fulltext

Time to take myocardial reperfusion injury seriously.

+ cite this

Hausenloy DJ and Yellon DM

The New England journal of medicine 359(5):518-20, 2008 Jul 31 - Who cited this? | PubMed ID: 18669431 | Fulltext

Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.

+ cite this

+ View Abstract

Hausenloy DJ and Yellon DM

Heart (British Cardiac Society) 94(6):706, 2008 Jun - Who cited this? | PubMed ID: 18480348 | Fulltext

Preconditioning and postconditioning: new strategies for cardioprotection.

+ cite this

+ View Abstract

Hausenloy DJ and Yellon DM

Diabetes, obesity & metabolism 10(6):451-9, 2008 Jun - Who cited this? | PubMed ID: 17825079 | Fulltext

Metformin protects the ischemic heart by the Akt-mediated inhibition of mitochondrial permeability transition pore opening.

+ cite this

+ View Abstract

Bhamra GS, Hausenloy DJ, Davidson SM, Carr RD, Paiva M, Wynne AM, Mocanu MM, and Yellon DM

Basic research in cardiology 103(3):274-84, 2008 May - Who cited this? | PubMed ID: 18080084 | Fulltext

Erythropoietin: ready for prime-time cardioprotection.

+ cite this

+ View Abstract

Riksen NP, Hausenloy DJ, and Yellon DM

Trends in pharmacological sciences 29(5):258-67, 2008 May - Who cited this? | PubMed ID: 18359096 | Fulltext

The novel adipocytokine visfatin exerts direct cardioprotective effects.

+ cite this

+ View Abstract

Lim SY, Davidson SM, Paramanathan AJ, Smith CC, Yellon DM, and Hausenloy DJ

Journal of cellular and molecular medicine, 2008 Apr 8 - Who cited this? | PubMed ID: 18400051 | Fulltext

Erythropoietin protects the human myocardium against hypoxia/reoxygenation injury via phosphatidylinositol-3 kinase and ERK1/2 activation.

+ cite this

+ View Abstract

Mudalagiri NR, Mocanu MM, Di Salvo C, Kolvekar S, Hayward M, Yap J, Keogh B, and Yellon DM

British journal of pharmacology 153(1):50-6, 2008 Jan - Who cited this? | PubMed ID: 17952111 | Fulltext

Myocardial reperfusion injury.

+ cite this

Ramaraj R, Forman MB, Jackson EK, Lowenstein CJ, Ibanez B, Cimmino G, Badimon JJ, Korantzopoulos PG, Goudevenos JA, Yellon DM, and Hausenloy DJ

The New England journal of medicine 357(23):2408-10, 2007 Dec 6 - Who cited this? | PubMed ID: 18057349 | Fulltext

Temporal changes in myocardial salvage kinases during reperfusion following ischemia: studies involving the cardioprotective adipocytokine apelin.

+ cite this

+ View Abstract

Smith CC, Mocanu MM, Bowen J, Wynne AM, Simpkin JC, Dixon RA, Cooper MB, and Yellon DM

Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 21(6):409, 2007 Dec - Who cited this? | PubMed ID: 17924178 | Fulltext

Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection.

+ cite this

+ View Abstract

Hausenloy DJ and Yellon DM

Heart failure reviews 12(3-4):217-34, 2007 Dec - Who cited this? | PubMed ID: 17541822 | Fulltext

The cardioprotective effect of necrostatin requires the cyclophilin-d component of the mitochondrial permeability transition pore.

+ cite this

+ View Abstract

Lim SY, Davidson SM, Mocanu MM, Yellon DM, and Smith CC

Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 21(6):467-9, 2007 Dec - Who cited this? | PubMed ID: 17965927 | Fulltext

Preconditioning and postconditioning: united at reperfusion.

+ cite this

+ View Abstract

Hausenloy DJ and Yellon DM

Pharmacology & therapeutics 116(2):173-91, 2007 Nov - Who cited this? | PubMed ID: 17681609 | Fulltext

Apelin-13 and apelin-36 exhibit direct cardioprotective activity against ischemiareperfusion injury.

+ cite this

+ View Abstract

Simpkin JC, Yellon DM, Davidson SM, Lim SY, Wynne AM, and Smith CC

Basic research in cardiology 102(6):518-28, 2007 Nov - Who cited this? | PubMed ID: 17694254 | Fulltext

The power of drug co-administration: smaller doses better outcomes.

+ cite this

Mocanu MM, Shakkottai P, and Yellon DM

Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 21(5):319-20, 2007 Oct - Who cited this? | PubMed ID: 17786547 | Fulltext

Transient limb ischemia induces remote preconditioning and remote postconditioning in humans by a K(ATP)-channel dependent mechanism.

+ cite this

+ View Abstract

Loukogeorgakis SP, Williams R, Panagiotidou AT, Kolvekar SK, Donald A, Cole TJ, Yellon DM, Deanfield JE, and MacAllister RJ

Circulation 116(12):1386-95, 2007 Sep 18 - Who cited this? | PubMed ID: 17724264 | Fulltext

Myocardial reperfusion injury.

+ cite this

Yellon DM and Hausenloy DJ

The New England journal of medicine 357(11):1121-35, 2007 Sep 13 - Who cited this? | PubMed ID: 17855673 | Fulltext

Ischemic preconditioning targets the reperfusion phase.

+ cite this

+ View Abstract

Hausenloy DJ, Wynne AM, and Yellon DM

Basic research in cardiology 102(5):445-52, 2007 Sep - Who cited this? | PubMed ID: 17530316 | Fulltext

Postconditioning protects human atrial muscle through the activation of the RISK pathway.

+ cite this

+ View Abstract

Sivaraman V, Mudalagiri NR, Di Salvo C, Kolvekar S, Hayward M, Yap J, Keogh B, Hausenloy DJ, and Yellon DM

Basic research in cardiology 102(5):453-9, 2007 Sep - Who cited this? | PubMed ID: 17546527 | Fulltext

Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial.

+ cite this

+ View Abstract

Hausenloy DJ, Mwamure PK, Venugopal V, Harris J, Barnard M, Grundy E, Ashley E, Vichare S, Di Salvo C, Kolvekar S, Hayward M, Keogh B, MacAllister RJ, and Yellon DM

Lancet 370(9587):575-9, 2007 Aug 18 - Who cited this? | PubMed ID: 17707752 | Fulltext

Preconditioning and postconditioning: the essential role of the mitochondrial permeability transition pore.

+ cite this

+ View Abstract

Lim SY, Davidson SM, Hausenloy DJ, and Yellon DM

Cardiovascular research 75(3):530-5, 2007 Aug 1 - Who cited this? | PubMed ID: 17512507 | Fulltext

Ischemic preconditioning is lost in aging hypertensive rat heart: independent effects of aging and longstanding hypertension.

+ cite this

+ View Abstract

Ebrahim Z, Yellon DM, and Baxter GF

Experimental gerontology 42(8):807-14, 2007 Aug - Who cited this? | PubMed ID: 17532161 | Fulltext

Myocardial ischaemia-reperfusion injury is attenuated by intact glucagon like peptide-1 (GLP-1) in the in vitro rat heart and may involve the p70s6K pathway.

+ cite this

+ View Abstract

Bose AK, Mocanu MM, Carr RD, and Yellon DM

Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 21(4):253-6, 2007 Aug - Who cited this? | PubMed ID: 17541736 | Fulltext

Necrostatin: a potentially novel cardioprotective agent?.

+ cite this

+ View Abstract

Smith CC, Davidson SM, Lim SY, Simpkin JC, Hothersall JS, and Yellon DM

Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 21(4):227-33, 2007 Aug - Who cited this? | PubMed ID: 17665295 | Fulltext

The evolving story of "conditioning" to protect against acute myocardial ischaemia-reperfusion injury.

+ cite this

Hausenloy DJ and Yellon DM

Heart (British Cardiac Society) 93(6):649-51, 2007 Jun - Who cited this? | PubMed ID: 17502643 | Fulltext

PTEN, the Achilles' heel of myocardial ischaemia/reperfusion injury?.

+ cite this

+ View Abstract

Mocanu MM and Yellon DM

British journal of pharmacology 150(7):833-8, 2007 Apr - Who cited this? | PubMed ID: 17293884 | Fulltext

Diazoxide-induced respiratory inhibition - a putative mitochondrial K(ATP) channel independent mechanism of pharmacological preconditioning.

+ cite this

+ View Abstract

Minners J, Lacerda L, Yellon DM, Opie LH, McLeod CJ, and Sack MN

Molecular and cellular biochemistry 294(1-2):11-8, 2007 Jan - Who cited this? | PubMed ID: 17136444 | Fulltext

Attenuated cardioprotective response to bradykinin, but not classical ischaemic preconditioning, in DOCA-salt hypertensive left ventricular hypertrophy.

+ cite this

+ View Abstract

Ebrahim Z, Yellon DM, and Baxter GF

Pharmacological research : the official journal of the Italian Pharmacological Society 55(1):42-8, 2007 Jan - Who cited this? | PubMed ID: 17079163 | Fulltext

Search Google Scholar for Yellon DM

Join Labmeeting

Organize and search your PDF collection
Collect papers
Search millions of papers
Keep up to date with paper alerts
Read your papers from anywhere
Recommend papers to colleagues
Manage your lab

Labmeeting is a web service for researchers. Sign up with your academic email address.

Individuals or corporations not affiliated with an academic institution can request a trial subscription.

Got a question?
The Labmeeting Network
has the answer.
Ask scientists at top universities like Harvard, Stanford, and MIT for their expert opinion!